All the news Showing 7 of 7 articles from: Drug-drug interactionsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals Liz Highleyman / 13 March 2017 AbbVie's investigational glecaprevir/pibrentasvir treatment for hepatitis C is not expected to interact with or require dose adjustment when taken with commonly used antiretroviral regimens, offering a new option for people with HIV/hepatitis C ... Sofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study Liz Highleyman / 21 July 2016 The once-daily co-formulation of sofosbuvir and velpatasvir was highly effective against all hepatitis C virus (HCV) genotypes in people with HIV/HCV co-infection and was safe and well tolerated in the ASTRAL-5 trial, according ... Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals Liz Highleyman / 11 March 2016 Sofosbuvir/velpatasvir, a forthcoming combination that effectively treats all hepatitis C virus (HCV) genotypes, can be safely used with most boosted antiretrovirals for people with HIV and HCV co-infection, according to a study presented ... New HCV protease inhibitors interact with a wide range of drugs used in treatment of psychiatric conditions Michael Carter / 28 June 2013 Recently licensed direct-acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV) infection do not pose a significant risk of psychiatric side-effects but have several important interactions with drugs used to treat ... Drug interactions may compromise response to boceprevir and telaprevir Liz Highleyman / 17 June 2013 Concurrent use of drugs that alter concentrations of boceprevir (Victrelis) or telaprevir (Incivek or Incivo) in the body may contribute to poor response to interferon-based triple therapy for chronic hepatitis C virus ... No evidence of an interaction between abacavir and ribavirin Michael Carter / 17 July 2012 There is no evidence of an interaction between the anti-HIV drug abacavir and the anti-hepatitis C agent ribavirin, investigators report in the online edition of AIDS. Some earlier research reported poorer hepatitis C treatment ... Studies look at interactions between new hepatitis C drugs and HIV antiretrovirals Liz Highleyman / 14 March 2012 Drug-drug interactions between direct-acting antiviral agents for hepatitis C and some antiretroviral medications used to treat HIV are common, but are often modest and can be managed with dose adjustments when treating people ... ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive